Fri, 01st Jan 2021 12:17
NEW DELHI, Jan 1 (Reuters) - India's drug regulator on
Friday approved a coronavirus vaccine developed by AstraZeneca
and Oxford University for emergency use, two sources
with knowledge of the matter told Reuters.
A representative of India's Central Drugs Standard Control
Organization (CDSCO), whose experts were meeting for the second
time this week, declined to comment.
(Reporting by Krishna N. Das and Nigam Prusty
Editing by Gareth Jones)
(Alliance News) - Stock prices in London opened in the red on Tuesday, with some US interest rate cut optimism cooling after hawkish words from Federa...
(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled ...
(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.
(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts signifi...
(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expe...
Astrazeneca (AZN)